# C4 Therapeutics, Inc.: Form 8-K, filed Apr 8, 2022

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2022-04-08
- Accepted by EDGAR: Apr 8, 2022, 13:21 ET
- Period: 2022-04-08
- Accession: 0001564590-22-013950
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000156459022013950/cccc-8k_20220408.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000156459022013950/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000156459022013950/cccc-8k_20220408.htm

Filed Apr 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-013950. Last ingested by Listed: Nov 5, 2026, 12:02 ET. No prices; not investment advice.